» Articles » PMID: 19765978

Clinical and Psychometric Validation of the EORTC QLQ-CR29 Questionnaire Module to Assess Health-related Quality of Life in Patients with Colorectal Cancer

Overview
Journal Eur J Cancer
Specialty Oncology
Date 2009 Sep 22
PMID 19765978
Citations 162
Authors
Affiliations
Soon will be listed here.
Abstract

This international study aimed to test the measurement properties of the updated European Organisation for Research and Treatment of Cancer (EORTC) questionnaire module for colorectal cancer, the QLQ-CR29. The QLQ-CR29 was administered with the QLQ-C30, core questionnaire, to 351 patients from seven countries. Questionnaire scaling and reliability were established and clinical and psychometric validity examined. Patient acceptability and understanding were assessed with a debriefing questionnaire. Multi-trait scaling analyses and face validity refined the module to four scales assessing urinary frequency, faecal seepage, stool consistency and body image and single items assessing other common problems following treatment for colorectal cancer. Scales distinguished between clinically distinct groups of patients and did not correlate with QLQ-C30 scales, demonstrating construct validity. The QLQ-CR29 scores were reproducible over time in stable health. The EORTC QLQ-CR29 demonstrates sufficient validity and reliability to support its use to supplement the EORTC QLQ-C30 to assess patient-reported outcomes during treatment for colorectal cancer in clinical trials and other settings.

Citing Articles

Quality of life outcomes in colorectal cancer survivors: insights from an observational study at a tertiary cancer center.

Marchewczyk P, Costeira B, da Silva F, Cavadas D, Abecasis N, Limbert M Qual Life Res. 2025; .

PMID: 39966198 DOI: 10.1007/s11136-025-03918-x.


Health-Related Quality of Life (HRQoL) Assessments in Research on Patients with Adult Rare Solid Cancers: A State-of-the-Art Review.

Padilla C, Bergerot C, Dijke K, Roets E, Bokova G, Innerhofer V Cancers (Basel). 2025; 17(3).

PMID: 39941756 PMC: 11816368. DOI: 10.3390/cancers17030387.


Assessment of the quality of life in metastatic colorectal cancer patients with KRAS gene mutant: a case-control study.

Bagrezaei F, Pourghassem Gargari B, Zamiri R, Safaiyan A, Alizadeh M BMC Cancer. 2025; 25(1):158.

PMID: 39871164 PMC: 11773744. DOI: 10.1186/s12885-025-13538-w.


Preservation of inferior mesenteric artery reduces short- and long-term defecatory dysfunction after laparoscopic colorectal resection for diverticular disease: An RCT.

Mari F, Chiarini L, Trampetti L, Savina C, Cosmi F, Cicolani A Surg Endosc. 2025; 39(3):1761-1769.

PMID: 39814952 DOI: 10.1007/s00464-024-11490-7.


Beyond survival: a comprehensive review of quality of life in rectal cancer patients.

Jung W Ann Coloproctol. 2025; 40(6):527-537.

PMID: 39748551 PMC: 11701447. DOI: 10.3393/ac.2024.00745.0106.